Go to content
UR Home

Involvement of cyclic guanosine monophosphate-dependent protein kinase I in renal antifibrotic effects of serelaxin

URN to cite this document:
DOI to cite this document:
Schlossmann, Jens ; Wetzl, Veronika ; Schinner, Elisabeth ; Kees, Frieder K. ; Hofmann, Franz ; Faerber, Lothar
Date of publication of this fulltext: 24 Jun 2016 08:50


Introduction: Kidney fibrosis has shown to be ameliorated through the involvement of cyclic guanosine monophosphate (cGMP) and its dependent protein kinase I (cGKI). Serelaxin, the recombinant form of human relaxin-II, increases cGMP levels and has shown beneficial effects on kidney function in acute heart failure patients. Antifibrotic properties of serelaxin are supposed to be mediated via ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -4239

Contact persons